36 results match your criteria: "WEST VIRGINIA UNIVERSITY COLLEGE OF LAW[Affiliation]"

A "Method of Use" to Prevent Generic and Biosimilar Market Entry.

N Engl J Med

February 2023

From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (S.S.T., A.S.); and West Virginia University College of Law, Morgantown (S.S.T.).

View Article and Find Full Text PDF

Recent Patent Reform Bills and Their Implications for Prescription Drugs.

JAMA

February 2023

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF

Filling a Federal Void: Promises and Perils of State Law in Addressing Women's Health Disparities.

J Law Med Ethics

September 2020

Valarie K. Blake, J.D., M.A., is an Associate Professor at the West Virginia University College of Law. Professor Blake has a B.S. from the University of Pittsburgh, a J.D. from the University of Pittsburgh School of Law, and an MA from Case Western Reserve University. Professor Blake's scholarly research is at the intersections of disability law, health law, medical ethics, stigma, civil rights, and insurance law. Michelle L. McGowan, Ph.D., is a Research Associate Professor in the Ethics Center and Division of General and Community Pediatrics at Cincinnati Children's Hospital Medical Center within the Departments of Pediatrics and Women's, Gender & Sexuality Studies at University of Cincinnati. She completed her Ph.D. in Women Studies at University of Washington and postdoctoral training in Bioethics at Case Western Reserve University. Her research focuses on the ethical and social implications of reproductive health policies on healthcare providers' and patients, with a particular emphasis on gendered health care disparities.

Federal law often avoids setting minimum standards for women's health and reproductive rights issues, leaving legislative and regulatory gaps for the states to fill as they see fit. This has mixed results. It can lead to state innovation that improves state-level health outcomes, informs federal health reform, and provides data on best practices for other states.

View Article and Find Full Text PDF

Unlabelled: Policy Points Stigma is an established driver of population-level health outcomes. Antidiscrimination laws can generate or alleviate stigma and, thus, are a critical component in the study of improving population health. Currently, antidiscrimination laws are often underenforced and are sometimes conceptualized by courts and lawmakers in ways that are too narrow to fully reach all forms of stigma and all individuals who are stigmatized.

View Article and Find Full Text PDF

As practicing clinicians, physicians are expected to uphold the ethical norms of their profession, including fidelity to patients and respect for patients' self-determination. At the same time, as individuals, physicians are moral agents in their own right and, like their patients, are informed by and committed to diverse cultural, religious, and philosophical traditions and beliefs. In some circumstances, the expectation that physicians will put patients' needs and preferences first may be in tension with the need to sustain the sense of moral integrity and continuity that grounds a physician's personal and professional life.

View Article and Find Full Text PDF

Oocyte donation raises conflicts of interest and commitment for physicians but little attention has been paid to how to reduce these conflicts in practice. Yet the growing popularity of assisted reproduction has increased the stakes of maintaining an adequate oocyte supply and (where appropriate) minimizing conflicts. A growing body of professional guidelines, legal challenges to professional self-regulation, and empirical research on the practice of oocyte donation all call for renewed attention to the issue.

View Article and Find Full Text PDF

A response to Pervasive sequence patents cover the entire human genome by J Rosenfeld and C Mason. Genome Med 2013, 5:27. See related Correspondence by Rosenfeld and Mason, http://genomemedicine.

View Article and Find Full Text PDF

The American Medical Association's Guides to the Evaluation of Permanent Impairment, Fourth Edition, is the most commonly used tool in the United States for rating permanent impairments for disability systems. The Guides, currently undergoing revision, has been the focus of considerable controversy. Criticisms have focused on 2 areas: internal deficiencies, including the lack of a comprehensive, valid, reliable, unbiased, and evidence-based system for rating impairments; and the way in which workers' compensation systems use the ratings, resulting in inappropriate compensation.

View Article and Find Full Text PDF